markers (data not shown), it may safely be presumed that parental consanguinity was present, albeit unknown, rather than that the mutation arose independently twice.
These findings establish the molecular-genetic etiology of a clinically severe form of atransferrinemia. The previously reported female patient 1 came to medical attention, for anemia, at the age of only 20 years. The previously reported boy [6] [7] [8] was first evaluated at the age of only 7 years, for pallor of new onset. Substitution of a polar asparagine residue for a negatively charged aspartate residue in the region of the human transferrin molecule encoded by exon 3 of TF appears largely to have abrogated synthesis or secretion of functional transferrin in our patient, whose disease was severe in early infancy. Molecular characterization of other instances of atransferrinemia may permit further correlations between mutation and clinical manifestations. 
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